SMAD5 and neoplasm: In this study, it was proved that lncRNA-SMAD5-AS1 was significantly down-regulated in DLBCL tissues and cell lines, and it could inhibit the tumor proliferation in vivo and in vitro, indicating that it may be a potential marker for diagnosis and treatment.